跳至主要内容
临床试验/JPRN-UMIN000015345
JPRN-UMIN000015345Enrolling By Invitation未知

Induced pluripotent stem cell (iPSC)-derived immortalized megakaryocyte cell lines (imMKCLs) from voluntary blood component donors with specific HLA haplotypes towards platelet products in transfusion therapy.

?Center for iPS Cell Research and Application (CiRA), Kyoto University?Kyoto University Hospital0 个研究点目标入组 3 人开始时间: 2014年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
Enrolling By Invitation
发起方
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • ?Voluntary, non-remunerated, healthy blood component donors
  • ?Homozygotes of HLA-A, HLA-B, and HLA-C
  • ?Blood type O
  • ?Individuals capable of giving voluntary, informed consent in writing

排除标准

  • ?The following viral infection:
  • Hepatic Virus B
  • Hepatic Virus C
  • Human Immunodeficiency Virus
  • Human T-cell leukemia virus
  • Human parvovirus B19
  • Cytomegalovirus
  • ?The following microbial infection:
  • Treponema pallidum
  • West e Virus
  • Chlamydiaceae
  • Genus Neisseria
  • Mycobacterium
  • Malaria parasites(Plasmodium spp.)
  • Trypanosoma cruzi
  • Trypanosoma brucei
  • ?Malignant neoplasm
  • ?Transmissible spongiform encephalopathy (including suspected case), Dementia or cognitive impairment, Stroke, Seizure
  • ?The following conditions:
  • Particular or genetic/hereditary disorders
  • Severe or uncontrolled metabolic or endocrinal disorders
  • Connective tissue diseases
  • Severe or uncontrolled hematologic diseases
  • Severe or uncontrolled hepatic disorders
  • ?Enrolling related studies of generating iPSC banks

研究者

发起方
?Center for iPS Cell Research and Application (CiRA), Kyoto University?Kyoto University Hospital

相似试验